Cargando…
Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
Alzheimer’s disease (AD) remains a major cause of morbidity and mortality worldwide, and despite extensive research, only a few drugs are available for management of the disease. One strategy has been to up-regulate cholinergic neurotransmission to improve cognitive function, but this approach has d...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Portland Press Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069568/ https://www.ncbi.nlm.nih.gov/pubmed/35571495 http://dx.doi.org/10.1042/NS20210004 |